These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1541910)

  • 1. Synthetic hexapeptides derived from the transmembrane envelope proteins of retroviruses suppress N-formylpeptide-induced monocyte polarization.
    Oostendorp RA; Schaaper WM; Post J; Meloen RH; Scheper RJ
    J Leukoc Biol; 1992 Mar; 51(3):282-8. PubMed ID: 1541910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunosuppressive retrovirus-derived hexapeptide interferes with intracellular signaling in monocytes and granulocytes through N-formylpeptide receptors.
    Oostendorp RA; Knol EF; Verhoeven AJ; Scheper RJ
    J Immunol; 1992 Aug; 149(3):1010-5. PubMed ID: 1634759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of lymphocyte proliferation by a retroviral p15E-derived hexapeptide.
    Oostendorp RA; Schaaper WM; Post J; Von Blomberg BM; Meloen RH; Scheper RJ
    Eur J Immunol; 1992 Jun; 22(6):1505-11. PubMed ID: 1534759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A synthetic peptide homologous to the envelope proteins of retroviruses inhibits monocyte-mediated killing by inactivating interleukin 1.
    Kleinerman ES; Lachman LB; Knowles RD; Snyderman R; Cianciolo GJ
    J Immunol; 1987 Oct; 139(7):2329-37. PubMed ID: 2821111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II.
    Ruegg CL; Monell CR; Strand M
    J Virol; 1989 Aug; 63(8):3250-6. PubMed ID: 2746730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.
    Cianciolo GJ; Copeland TD; Oroszlan S; Snyderman R
    Science; 1985 Oct; 230(4724):453-5. PubMed ID: 2996136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections.
    Haraguchi S; Good RA; James-Yarish M; Cianciolo GJ; Day NK
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5568-71. PubMed ID: 7777549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of human interferon-gamma production by a 17 amino acid peptide homologous to the transmembrane envelope protein of retroviruses: evidence for a primary role played by monocytes.
    Haraguchi S; Liu WT; Cianciolo GJ; Good RA; Day NK
    Cell Immunol; 1992 May; 141(2):388-97. PubMed ID: 1576656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E.
    Harris DT; Cianciolo GJ; Snyderman R; Argov S; Koren HS
    J Immunol; 1987 Feb; 138(3):889-94. PubMed ID: 2433333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic peptide homologous to the envelope proteins of retroviruses shares a cross-reacting epitope with the CD4 receptor.
    Rothmann J; Hassan NF; Campbell DE; Kamani N; Douglas SD
    J Clin Microbiol; 1990 Jan; 28(1):112-5. PubMed ID: 1688871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of synthetic peptide from retroviral transmembrane protein p15E on murine spleen cell proliferation and bone marrow hemopoietic precursor colony formation.
    Chernukhin IV; Khaldoyanidi SK; Kozlov VA; Gaidul KV
    Biomed Pharmacother; 1993; 47(9):397-402. PubMed ID: 8068862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation by peptide analogs of retroviral envelope protein.
    Mehrotra S; Mishra KP; Yadav VS; Bhattacharya M; Pandey D; Haq W; Singh VK
    Peptides; 2003 Jul; 24(7):979-85. PubMed ID: 14499276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human IFN-gamma production is inhibited by a synthetic peptide homologous to retroviral envelope protein.
    Ogasawara M; Cianciolo GJ; Snyderman R; Mitani M; Good RA; Day NK
    J Immunol; 1988 Jul; 141(2):614-9. PubMed ID: 2968406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the immunosuppressive activity of CKS-17, a synthetic retroviral envelope peptide, by muramyl dipeptide.
    Gauduin MC; Vogel FR; Simon JP; Audibert FA; Chedid LA
    Viral Immunol; 1993; 6(3):175-83. PubMed ID: 8292225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive actions of retroviruses.
    Good RA; Ogasawara M; Liu WT; Lorenz E; Day NK
    Lymphology; 1990 Jun; 23(2):56-9. PubMed ID: 2170777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor.
    Gao JL; Becker EL; Freer RJ; Muthukumaraswamy N; Murphy PM
    J Exp Med; 1994 Dec; 180(6):2191-7. PubMed ID: 7964494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synthetic peptide homologous to retroviral envelope protein down-regulates TNF-alpha and IFN-gamma mRNA expression.
    Haraguchi S; Good RA; Cianciolo GJ; Day NK
    J Leukoc Biol; 1992 Oct; 52(4):469-72. PubMed ID: 1402393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: immunosuppression, immunogenicity, and relation to immunosuppressive tumor products.
    Nelson M; Nelson DS; Cianciolo GJ; Snyderman R
    Cancer Immunol Immunother; 1989; 30(2):113-8. PubMed ID: 2598177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of the Putative Immunosuppressive Domain of the Retroviral Envelope Glycoprotein Compromises Infectivity.
    Eksmond U; Jenkins B; Merkenschlager J; Mothes W; Stoye JP; Kassiotis G
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic peptide corresponding to a conserved domain of the retroviral protein p15E blocks IL-1-mediated signal transduction.
    Gottlieb RA; Lennarz WJ; Knowles RD; Cianciolo GJ; Dinarello CA; Lachman LB; Kleinerman ES
    J Immunol; 1989 Jun; 142(12):4321-8. PubMed ID: 2524528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.